Stock Track | AIM VACCINE Soars 6.78% Intraday on Plans for Beijing Stock Exchange A-Share Listing

Stock Track

Apr 02

AIM VACCINE's stock price soared 6.78% during intraday trading following the company's announcement of plans to pursue an A-share listing on the Beijing Stock Exchange.

The surge comes after AIM VACCINE passed a resolution to issue up to 40 million additional domestic shares and announced its intention to apply for listing on the Beijing Stock Exchange. If successful, the company would become the first to transition from a Hong Kong listing to a Beijing Stock Exchange listing, setting a precedent for other biopharmaceutical firms.

Market analysts note that similar vaccine companies like CanSino Biologics have seen their A-share valuations trade at a significant premium to their H-shares. The potential "H+A" dual-listing strategy is expected to boost AIM VACCINE's Hong Kong stock valuation, enhance secondary market liquidity, and significantly improve the company's brand value and business development prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1170690188"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170690188\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170690188?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 11:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170690188","market":"nz","top_or_hot":-1,"title":"Stock Track | AIM VACCINE Soars 6.78% Intraday on Plans for Beijing Stock Exchange A-Share Listing","media":"Stock Track","content":"<p>AIM VACCINE's stock price soared 6.78% during intraday trading following the company's announcement of plans to pursue an A-share listing on the Beijing Stock Exchange.</p><p>The surge comes after AIM VACCINE passed a resolution to issue up to 40 million additional domestic shares and announced its intention to apply for listing on the Beijing Stock Exchange. If successful, the company would become the first to transition from a Hong Kong listing to a Beijing Stock Exchange listing, setting a precedent for other biopharmaceutical firms.</p><p>Market analysts note that similar vaccine companies like CanSino Biologics have seen their A-share valuations trade at a significant premium to their H-shares. The potential \"H+A\" dual-listing strategy is expected to boost AIM VACCINE's Hong Kong stock valuation, enhance secondary market liquidity, and significantly improve the company's brand value and business development prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AIM VACCINE Soars 6.78% Intraday on Plans for Beijing Stock Exchange A-Share Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AIM VACCINE Soars 6.78% Intraday on Plans for Beijing Stock Exchange A-Share Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-02 11:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AIM VACCINE's stock price soared 6.78% during intraday trading following the company's announcement of plans to pursue an A-share listing on the Beijing Stock Exchange.</p><p>The surge comes after AIM VACCINE passed a resolution to issue up to 40 million additional domestic shares and announced its intention to apply for listing on the Beijing Stock Exchange. If successful, the company would become the first to transition from a Hong Kong listing to a Beijing Stock Exchange listing, setting a precedent for other biopharmaceutical firms.</p><p>Market analysts note that similar vaccine companies like CanSino Biologics have seen their A-share valuations trade at a significant premium to their H-shares. The potential \"H+A\" dual-listing strategy is expected to boost AIM VACCINE's Hong Kong stock valuation, enhance secondary market liquidity, and significantly improve the company's brand value and business development prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06660","symbol_name":"艾美疫苗","start_time":0,"source_url":"","article_id":"1170690188","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170690188","pubTimestamp":1775098980,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"AIM VACCINE's stock price soared 6.78% during intraday trading following the company's announcement of plans to pursue an A-share listing on the Beijing Stock Exchange.The surge comes after AIM...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06660":"艾美疫苗"},"translate_title":"股票赛道|拟北交所A股上市AIM疫苗盘中大涨6.78%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06660":1},"content_text":"AIM VACCINE's stock price soared 6.78% during intraday trading following the company's announcement of plans to pursue an A-share listing on the Beijing Stock Exchange.The surge comes after AIM VACCINE passed a resolution to issue up to 40 million additional domestic shares and announced its intention to apply for listing on the Beijing Stock Exchange. If successful, the company would become the first to transition from a Hong Kong listing to a Beijing Stock Exchange listing, setting a precedent for other biopharmaceutical firms.Market analysts note that similar vaccine companies like CanSino Biologics have seen their A-share valuations trade at a significant premium to their H-shares. The potential \"H+A\" dual-listing strategy is expected to boost AIM VACCINE's Hong Kong stock valuation, enhance secondary market liquidity, and significantly improve the company's brand value and business development prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}